In a recent strategic move, Sheppard, Mullin, Richter & Hampton has expanded its capabilities in intellectual property by recruiting three seasoned partners from Perkins Coie. The firm announced that David Fournier, Allison Glasunow, and Kourtney Mueller Merrill have joined their intellectual property practice group and life sciences industry team based in Washington, D.C.
David Fournier brings a wealth of experience in advising clients on patents related to pharmaceuticals, biologics, medical devices, and consumer products. His expertise includes exclusivity planning, strategic global portfolio development, and regulatory compliance. Fournier has a significant track record in handling abbreviated new drug application litigation, Orange Book listings, patent term extensions, FDA exclusivity, and post-grant proceedings.
Allison Glasunow is known for her advice to life sciences companies on patent strategies and portfolio development. Alongside her, Kourtney Mueller Merrill enhances the team with her experience, likely contributing to the firm’s breadth in managing complex intellectual property challenges in the life sciences sector. This strategic hiring aligns with Sheppard Mullin’s aim to bolster its resources and offer comprehensive services to clients navigating the intricate landscape of intellectual property law.